Please login to the form below
FREE WEBINAR: End-to-end patient strategy: making a treatment for patients, with patients
Origins announces the first speaker on the panel of our upcoming webinar
Origins is hosting the next in its series of free webinars on Tuesday 13th December at 2pm UK time: “End-to-end patient strategy: making a treatment for patients, with patients”
Director of Origins, Su Smith will be joined by a panel of passionate industry experts to explore the integration of patient engagement in all stages of a product lifecycle. what does ‘end-to-end’ encompass, and what does this mean for drug development companies, regulators, healthcare professionals and, of course, patients themselves? The panel will discuss the past, present and future of patient engagement.
Our first confirmed speaker is Daniel de Schryver, Patient Engagement & Advocacy Lead, Europe, Middle-East and Africa, Janssen. In this function, Daniel is part of a global multi-functional leadership team that helps the company to engage with patients in a systematic way, and helps to build partnerships in developing solutions that better meet the existing needs. He also leads a group of colleagues in the region who play a crucial role in working towards a more collaborative approach in innovation.
Watch this space for more speaker announcements.
You can register for the webinar here: https://us06web.zoom.us/webinar/register/WN_fZ5oz08hQaqCuZjI_a6eXw
DANIEL DE SCHRYVERCompany Details
Origins - The Patient Focused Specialists
Address:
One Fleet
Ancells Road
Fleet
Hampshire
GU51 2UN
United Kingdom
Latest content on this profile
- Origins' Solutions Offering Explained
- Providing patient solutions that are wanted, needed, accessible, and fit for purpose can help companies to increase the value and success of their products and gain respect and recognition for being truly patient focused.Su Smith explains why this important, and how Origins supports our clients to co-create patient focused materials, at all stages of the product lifecycleFor more about Origins and our different services, visit our website www.origins-patients.com, or contact Su Smith or Mark Corbett to set up a call.
Origins - The Patient Focused Specialists
- Origins' Knowledge Centre
- A collection of resources including webinar recordings, publications and short videos to help you be more patient focussed
Origins - The Patient Focused Specialists
- Origins Insights Offering Explained
- Origins believe that the patient voice not only should but must be included at all stages of the product lifecycle, we believe the question is no longer about why, but how the patient voice is included from drug discovery to commercialisation. In this short video Sheetal Padania describes how Origins’ insights offering helps our clients to understand patient opinion and experience, through a variety of methodologies.For more about Origins and our different services, visit our website: www.origins-patients.com, or contact Sheetal Padania or Mark Corbett to set up a call.
Origins - The Patient Focused Specialists
- Introduction to Origins
- In this short video Mark Corbett, Chief Innovation Officer at Resonant Group, gives a brief introduction to Origins, the patient focused specialist agency.If you'd like to know more, visit the Origins' website www.origins-patients.com or contact Mark directly on LinkedIn.
Origins - The Patient Focused Specialists
- Origins' Strategy Offering Explained
- What do we mean when we say that at Origins, we provide patient focused strategies throughout the product lifecycle? In this short video Origins’ Director Su Smith explains our strategy offering and what it could mean for you.For more about Origins and our different services, visit our website: www.origins-patients.com or contact Su Smith or Mark Corbett to set up a call.
Origins - The Patient Focused Specialists
- End-to-end patient strategy: Making a treatment for patients, with patients
- The integration of patient engagement in all stages of a product lifecycle is starting to become much more commonplace and you may start to hear the term end-to-end patient strategy used more and more often. But what does ‘end-to-end’ encompass, and what does this mean for drug development companies, regulators, healthcare professionals and, of course, patients themselves? Here we explore the concept and why patient voices need to be loud, and heard, during all phases of drug development...
Origins - The Patient Focused Specialists
